Clinical Trial

Cardiac Amyloidosis Registry of University Hospital Leipzig

Recruiting
View on ClinicalTrials.gov →
Summary
This is a clinical registry of patients with cardiac amyloidosis being treated at University Hospital Leipzig. The aim of the registry is to collect detailed information about clinical events, symptoms, imaging, biomarkers, comorbidities, and treatment from routine patient management which would not be provided by randomized clinical trails.
Trial Details
NCT Number NCT06129656
Lead Sponsor University of Leipzig
Conditions Cardiac Amyloidosis
Enrollment 500 participants
Start Date 2023-05-01
Primary Completion 2033-05 (estimated)
Study Completion 2033-05 (estimated)
Updated on ClinicalTrials.gov 2023-11-13